Pharvaris Bv Stock Analysis
| PHVS Stock | USD 23.25 0.48 2.02% |
Pharvaris BV is undervalued with Real Value of 27.85 and Hype Value of 23.28. The main objective of Pharvaris stock analysis is to determine its intrinsic value, which is an estimate of what Pharvaris BV is worth, separate from its market price. There are two main types of Pharvaris' stock analysis: fundamental analysis and technical analysis.
The Pharvaris stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Pharvaris is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Pharvaris Stock trading window is adjusted to America/New York timezone.
Pharvaris | Build AI portfolio with Pharvaris Stock |
Pharvaris Stock Analysis Notes
About 89.0% of the company shares are owned by institutional investors. The book value of Pharvaris was at this time reported as 4.14. The company recorded a loss per share of 3.26. Pharvaris BV had not issued any dividends in recent years. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company was incorporated in 2015 and is based in Leiden, the Netherlands. Pharvaris is traded on NASDAQ Exchange in the United States. To find out more about Pharvaris BV contact CPA MBA at 31 712036410 or learn more at https://pharvaris.com.Pharvaris BV Investment Alerts
| Pharvaris BV is way too risky over 90 days horizon | |
| Pharvaris BV appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (132.4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pharvaris BV currently holds about 201.38 M in cash with (120.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.96. | |
| Pharvaris BV has a poor financial position based on the latest SEC disclosures | |
| Over 89.0% of the company shares are owned by institutional investors |
Pharvaris BV Upcoming and Recent Events
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Pharvaris Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.27 B.Technical Drivers
As of the 19th of July, Pharvaris holds the Risk Adjusted Performance of 0.1712, coefficient of variation of 572.94, and Semi Deviation of 3.02. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharvaris, as well as the relationship between them. Please check Pharvaris BV market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Pharvaris BV is priced some-what accurately, providing market reflects its current price of 23.25 per share. Given that Pharvaris has jensen alpha of 0.7361, we recommend you to check out Pharvaris BV's recent market performance to make sure the company can sustain itself at a future point.Pharvaris BV Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of Pharvaris for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Pharvaris BV short-term fluctuations and highlight longer-term trends or cycles.
Pharvaris Outstanding Bonds
Pharvaris issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharvaris BV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharvaris bonds can be classified according to their maturity, which is the date when Pharvaris BV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Pharvaris Predictive Daily Indicators
Pharvaris intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pharvaris stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Pharvaris Forecast Models
Pharvaris' time-series forecasting models are one of many Pharvaris' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharvaris' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Pharvaris Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharvaris prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharvaris shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharvaris. By using and applying Pharvaris Stock analysis, traders can create a robust methodology for identifying Pharvaris entry and exit points for their positions.
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company was incorporated in 2015 and is based in Leiden, the Netherlands. Pharvaris is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pharvaris to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.